DIL
CRBP icon

Deeter Investments LLP’s Corbus Pharmaceuticals CRBP Stock Holding History

Deeter Investments LLP’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$611K Buy
+75,000
New +$926K 0.13% 69

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deeter Investments LLP's CRBP Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Corbus Pharmaceuticals (CRBP) in Q4 2025: 75,000 shares worth $611K. The stake represents 0.13% of the portfolio and ranks #69 among its holdings.

101 funds tracked by Wall St. Rank hold CRBP as of Q4 2025.

  • Deeter Investments LLP held 75,000 shares of Corbus Pharmaceuticals worth $611K as of Q4 2025.
  • Corbus Pharmaceuticals was a new Deeter Investments LLP position in Q4 2025.
  • Corbus Pharmaceuticals made up 0.13% of Deeter Investments LLP's portfolio in Q4 2025, its #69 holding.
  • 101 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.